The Company Invites Investors, Industry Executives, and Analysts to Attend Its Real-time, Interactive Presentation SAN DIEGO, CA - February 18, 2025 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. ("Sigyn" ...
The Board of Directors of Sampo plc has today resolved on a share split by way of a share issue without consideration in proportion to shares owned by shareholders. The resolution is based on the ...
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at ...
SAN DIEGO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a developer of next-generation blood purification technologies to treat ...
Learn more about the event at www.virtualinvestorconferences.com. Sigyn Therapeutics is developing next-generation blood purification therapies to address cancer and life-threatening infectious ...
Learn more about the event at www.virtualinvestorconferences.com. Sigyn Therapeutics is developing next-generation blood purification therapies to address cancer and life-threatening infectious ...
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com SAN DIEGO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Sigyn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback